PureScience: The new generation of RNA vaccines that require ultra-low doses & help ramp up production

After the incredible success with mRNA vaccines, researchers are now close to having well-working & self-amplifying RNA vaccines. The new RNA technology can generate immune response at ultra-low doses and help scale-up production. ThePrint’s Sandhya Ramesh explains the ongoing work into the technology, especially at Imperial College London, in #PureScience